Complementary medicine use in cardiovascular disease: A clinician's viewpoint

Medical Journal of Australia

Volumn 195, Issue 11, 2011, Pages 654-656

  Kiat, Hosen ^a   Bin, Yu Sun ^b   Grant, Suzanne ^c   Chang, Dennis Hsu Tung ^c  

^a MACQUARIE UNIVERSITY   (Australia)

^b Cardiac Health Institute   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; COLECALCIFEROL; EDETIC ACID; FISH OIL; HERBACEOUS AGENT; MELATONIN; OMEGA 3 FATTY ACID; PRESCRIPTION DRUG; UBIDECARENONE;

ALTERNATIVE MEDICINE; ATTITUDE TO HEALTH; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COMORBIDITY; CORONARY ARTERY DISEASE; CRATAEGUS; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; EDUCATIONAL STATUS; GARLIC; HEALTH CARE NEED; HEALTH CARE QUALITY; HEALTH EDUCATION; HEART FAILURE; HEART INFARCTION; HERB DRUG INTERACTION; HERBAL MEDICINE; HOMEOPATHY; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INCOME; INSOMNIA; ISCHEMIC HEART DISEASE; MYALGIA; MYOPATHY; NOTE; PATIENT COMPLIANCE; PATIENT SAFETY; PHYSICIAN ATTITUDE; PRESCRIPTION; RHABDOMYOLYSIS; RISK BENEFIT ANALYSIS; TEA;

EID: 84857080609     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja10.10976     Document Type: Note

References (19)

1. Australian Institute of Health and Welfare. Australia's Health 2008. Canberra: AIHW, 2008. (AIHW Cat. No. AUS 99.) http://www.aihw.gov.au/publicationdetail/?id=6442468102 (accessed Oct 2011).
2. Australian Institute of Health and Welfare. General practice activity in Australia 2005-06. Canberra: AIHW, 2007. (AIHW Cat. No. GEP 19.) http://www.aihw.gov.au/publication-detail/?id=6442467936 (accessed Oct 2011).
3. Therapeutic Drugs Administration. The regulation of complementary medicines in Australia- an overview. Canberra: TGA, 2007. http://www.tga.gov.au/industry/cm-basics-regulation-overview.htm (accessed Oct 2011).
4. Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ 2000; 78: 252-257.
5. Bin YS, Kiat H. Prevalence of dietary supplement use in patients with proven or suspected cardiovascular disease. Evid Based Complement Alternat Med 2011;article ID: 632829. doi: 10.1155/2011/632829.
6. Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol 2010; 55: 515-525.
7. Cohen PA, Ernst E. Safety of herbal supplements: a guide for cardiologists. Cardiovasc Ther 2010; 28: 246-253.
8. Izzo AA, Di Carlo G, Borrelli F, Ernst E. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol 2005; 98: 1-14.
9. Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 2004; 12: 90-98.
10. Bishop FL, Lewith GT. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. Evid Based Complement Alternat Med 2010; 7: 11-28.
11. Bishop FL, Yardley L, Lewith GT. A systematic review of beliefs involved in the use of complementary and alternative medicine. J Health Psychol 2007; 12: 851-867.
12. Pirotta M, Kotsirilos V, Brown J, et al. Complementary medicine in general practice- a national survey of GP attitudes and knowledge. Aust Fam Physician 2010; 39: 946-950.
13. Balk EM, Lichtenstein AH, Chung M, et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006; 189: 19-30.
14. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001; 285: 304-312.
15. Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002; 287: 1815-1821.
16. Zhao YT, Chen Q, Sun YX, et al. Prevention of sudden cardiac death withomega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann Med 2009; 41: 301-310.
17. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy: a systematic review. J Am Coll Cardiol 2007; 49: 2231-2237.
18. Rosenfeldt F, Hilton D, Pepe S, Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors 2003; 18: 91-100.
19. Lee MS, Pittler MH, Guo R, Ernst E. Qigong for hypertension: a systematic review of randomized clinical trials. J Hypertens 2007; 25: 1525-1532.